Ribonucleic Acid News and Research

RSS

mRNA booster vaccination found to protect aged mice against the Omicron variant of SARS-CoV-2

A new study examined the protective effect of the mRNA booster vaccine against the SARS-CoV-2 Omicron variant in 21-month-old mice.

26 Apr 2022

Researchers use mouse model to explore correlation of impaired interferon-mediated immune response with severe COVID-19

Researchers developed a highly pathogenic mouse-adapted SARS-CoV-2 strain to model mild, moderate, or COVID-19.

26 Apr 2022

Canine COVID-19 vaccine could prevent reverse transmission of SARS-CoV-2

The new study, published in the journal Vaccines, reports on an attempt to use the SARS-CoV-2 spike subunit protein to elicit an immune reaction.

26 Apr 2022

Increased power and amplitude of memory B cells after SARS-CoV-2 mRNA booster

In a recent study published in the journal Nature, the researchers investigated the impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) booster vaccine on memory B cells.

25 Apr 2022

Scientists show how T cells may help protect against severe COVID

In a recent study published in the Clinical Infectious Diseases journal, the researchers summarized the perspectives and observations on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related adaptive immunity.

25 Apr 2022

COVID-19 vaccine can elicit a distinct T cell-dominant immune-mediated hepatitis

In a recent study published in the Journal of Hepatology, researchers reported that the coronavirus disease 2019 (COVID-19) vaccination could elicit a distinct T cell-dominant immune-mediated hepatitis.

25 Apr 2022

Vaccine effectiveness against COVID-19 infection and related hospitalization

Researchers assessed the effectiveness of COVID-19 vaccines against COVID-19 infections and related hospitalizations.

25 Apr 2022

Anti-SARS-CoV-2 spike antibody levels following COVID-19 BNT162b2 vaccination

Researchers assessed factors influencing the anti-severe acute respiratory syndrome coronavirus 2 spike antibodies after SARS-CoV-2 BNT162b2 vaccination.

25 Apr 2022

Vaccine effectiveness against symptomatic disease caused by the Omicron and Delta variants in England

The researchers aimed to estimate how effective vaccination was against severe COVID-19, caused by Omicron and Delta variants of the virus, in England.

25 Apr 2022

The challenges of Omicron

A new review published in sums up the position of Omicron as a potential threat to human health, especially in the context of controlling this pandemic.

25 Apr 2022

Prior COVID-19 protects against subsequent infections

In a recent study published in the Journal of American Medical Association (JAMA), researchers evaluated the duration and level of protection conferred by a coronavirus disease 2019 (COVID-19) infection among non-vaccinated subjects.

25 Apr 2022

Booster vaccine provides similar protection in SARS-CoV-2 naive and convalescent individuals

Researchers estimate the effectiveness of primary vaccination and a booster dose in people with and without prior SARS-CoV-2 infection.

24 Apr 2022

4% patients with COVID-19 shed fecal viral RNA 10 months after diagnosis

Researchers explore how the presence of SARS-CoV-2 RNA in feces can be associated with the presentation of GI symptoms.

24 Apr 2022

Efficacy of vaccination against SARS-CoV-2 Omicron BA.1 and BA.2 sublineages in Sweden

Researchers compared the vaccine effectiveness against infections by SARS-CoV-2 variant of concern Omicron BA.1 and BA.2 sublineages in Sweden.

22 Apr 2022

The diversity of transcriptional targets between four different coronavirus nsp1 proteins

Researchers investigated variations in the host immune response-elicited by non-structural protein 1 of coronaviruses.

22 Apr 2022

Study suggests SARS-CoV-2 is undergoing evolutionary changes at the functional RNA level in addition to the amino acid level

Researchers demonstrated SARS-CoV-2 evolution at the transcriptional level.

22 Apr 2022

Ribonucleic Acid News and Research

mRNA booster vaccination found to protect aged mice against the Omicron variant of SARS-CoV-2

Researchers use mouse model to explore correlation of impaired interferon-mediated immune response with severe COVID-19

Canine COVID-19 vaccine could prevent reverse transmission of SARS-CoV-2

Increased power and amplitude of memory B cells after SARS-CoV-2 mRNA booster

Scientists show how T cells may help protect against severe COVID

COVID-19 vaccine can elicit a distinct T cell-dominant immune-mediated hepatitis

Vaccine effectiveness against COVID-19 infection and related hospitalization

Anti-SARS-CoV-2 spike antibody levels following COVID-19 BNT162b2 vaccination

Vaccine effectiveness against symptomatic disease caused by the Omicron and Delta variants in England

The challenges of Omicron

Prior COVID-19 protects against subsequent infections

Booster vaccine provides similar protection in SARS-CoV-2 naive and convalescent individuals

4% patients with COVID-19 shed fecal viral RNA 10 months after diagnosis

Efficacy of vaccination against SARS-CoV-2 Omicron BA.1 and BA.2 sublineages in Sweden

The diversity of transcriptional targets between four different coronavirus nsp1 proteins

Study suggests SARS-CoV-2 is undergoing evolutionary changes at the functional RNA level in addition to the amino acid level

Study demonstrates that a low-dose, bivalent, unmodified mRNA vaccine against SARS-CoV-2 is highly efficacious

Booster dose of BNT162b2 mRNA vaccine induces a high cross-neutralizing response against SARS-CoV-2 variants

COVID-19 mRNA vaccine protects against ICU admission for 1 year

CRISPR-based detection of SARS-CoV-2 RNA directly from patient swabs

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News